Reduction of the risk of cervical intraepithelial neoplasia in HIV-infected women treated with highly active antiretroviral therapy

Acta Biomedica de l'Ateneo Parmense

Volumn 78, Issue 1, 2007, Pages

  Soncini, Emanuele ^a   Zoncada, Alessia ^a   Condemi, Vittorio ^a   Degli Antoni, Anna ^a   Bocchialini, Elena ^a   Soregotti, Paola ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Antiretroviral therapy, highly active; Cervical intraepithelial neoplasia; Cervix neoplasms; Cervix uteri histopathology; Cohort studies; Colposcopy; Vaginal smear

Indexed keywords

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; CANCER GRADING; CANCER PREVENTION; CANCER RISK; COLPOSCOPY; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; RISK REDUCTION; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HIV INFECTIONS; HUMANS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 34447501794     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 1993; 269: 729-30.
2. Ellerbrock TV, Chiasson MA, Bush TJ, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000; 283: 1031-7.
3. Jan N, Moscicki AB. Human papillomavirus infections in women with HIV disease: prevalence, risk, and management. AIDS Read 2000; 10: 659-68.
4. Heard I, Tassie J, Schmitz V, Mandelbrot L, Kazatchkine MD, Orth G: Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load. Obstet Gynecol 2000; 96: 403-9.
5. The Bethesda System for reporting cervical/vaginal cytologic diagnoses: revised after the second National Cancer Institute Workshop, April 29-30, 1991. Acta Cytol 1993; 37: 115-24.
6. Coppleson M, Pixley E. International colpolscopic terminology. In Coppleson M. (ed): Gynaecological Oncology. Edinburg: Churchill Livingstone, 1992.
7. Heard I, Tassie JM, Kazatchkine MD, Orth G. Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women. AIDS 2002; 16: 1799-802.
8. Heard I, Potard V, Foulot H, Chapron C, Costagliola D, Kazatchkine MD. High rate of recurrence of cervical intraepithelial neoplasia after surgery in HIV-positive women. J Acquir Immune Defic Syndr 2005; 39: 412-8.
9. Minkoff H, Ahdieh L, Massad LS, et al. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 2001; 15: 2157-64.
10. Robinson WR, Hamilton CA, Michaels SH, Kissinger P. Effect of excisional therapy and highly active antiretroviral therapy on cervical intraepithelial neoplasia in women infected with human immunodeficiency virus. Am J Obstet Gynecol 2001; 184: 538-43.
11. Lillo FB, Ferrari D, Veglia F, et al. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis 2001; 184: 547-51.
12. Del Mistro A, Bertorelle R, Franzetti M, et al. Antiretroviral therapy and the clinical evolution of human papillomavirus-associated genital lesions in HIV-positive women. Clin Infect Dis 2004; 38: 737-742.
13. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 51(RR-6): 1-78.